EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world study

Xinxin Zeng, Hao Yao, Aole Li, Fei Wang, Juanjuan Liu, Yuhang Wu, Xingyu Dong, Xin Yu, Hongmei Xu, Ping Liu, Juan Ma, Qingshan Cai und 7 weitere

Journal of Infection and Public Health · 2026

DOI: 10.1016/j.jiph.2025.103022 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Infection and Public Health, 2026. Verfasst von Xinxin Zeng und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, H…. Hauptthemen laut MEDLINE: Pyrazinamide, Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinamideAntitubercular AgentsTuberculosisHumansRetrospective StudiesFemaleMaleChildChild, PreschoolInfantAdolescentDrug Therapy, Combination

Stichwörter der Autor:innen

ChildrenMulticenter studyPyrazinamideSafetyTuberculosis

Substanzen

PyrazinamideAntitubercular Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang 310052, China.
  • Department of Tuberculosis Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
  • Department of Tuberculosis, The Fifth People's Hospital of Suzhou, Suzhou, Jiangsu 215211, China.
  • Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400042, China.
  • Department of Tuberculosis, Shanghai Public Health Clinical Center, Shanghai 200083, China.
  • Department of Infectious Diseases, Qinghai Province Women and Children's Hospital, Xining, Qinghai 810006, China.

Zitieren

APA

Zeng, X., Yao, H., Li, A., Wang, F., Liu, J., Wu, Y., Dong, X., Yu, X., Xu, H., Liu, P., Ma, J., Cai, Q., Li, H., Tian, M., Fang, Q., Yang, G., Zeng, X., Chen, B., & Huang, L. (2026). The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.103022

Vancouver

Zeng X, Yao H, Li A, Wang F, Liu J, Wu Y, et al. The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world study. Journal of Infection and Public Health. 2026. doi:10.1016/j.jiph.2025.103022

BibTeX
@article{Zeng2026,
  author = {Zeng, Xinxin and Yao, Hao and Li, Aole and Wang, Fei and Liu, Juanjuan and Wu, Yuhang and Dong, Xingyu and Yu, Xin and Xu, Hongmei and Liu, Ping and Ma, Juan and Cai, Qingshan and Li, Haiyan and Tian, Man and Fang, Qing and Yang, Guangxu and Zeng, Xianhui and Chen, Bin and Huang, Lisu},
  title = {The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world study},
  journal = {Journal of Infection and Public Health},
  year = {2026},
  doi = {10.1016/j.jiph.2025.103022}
}
Kostenlos starten →